Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API’s, Intermediates and Nutraceutical ingredients
Financial Results:
Divis Laboratories Ltd reported Revenues for Q4FY25 of ₹2,585.00 Crores up from ₹2,303.00 Crore year on year, a rise of 12.24%.
Total Expenses for Q4FY25 of ₹1,807.00 Crores up from ₹1,669.00 Crores year on year, a rise of 8.27%.
Consolidated Net Profit of ₹662.00 Crores up 23.05% from ₹538.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹24.94, up 23.04% from ₹20.27 in the same quarter of the previous year.